⌘K

Login Start Free

Home/Filings/4/0001628280-26-000964

4//SEC Filing

Teehan Brendan 4

Accession 0001628280-26-000964

CIK 0001396814other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:30 PM ET

Size

5.2 KB

Accession

0001628280-26-000964

Insider Transaction Report

Form 4

Period: 2025-12-31

Pacira BioSciences, Inc.PCRX

Chief Commercial Officer

Transactions

Award
Common Stock
2025-12-31$10.76/sh+402.268$4,330→ 54,402.268 total

Footnotes (1)

[F1]Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.

Documents

1 file

4
wk-form4_1767738624.xmlPrimary
FORM 4

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1

filerCIK 0001891900

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 5:30 PM ET
Size: 5.2 KB

View on SEC.gov